Observational studyJournal of atherosclerosis and thrombosis2019
Five-Year Patency and its Predictors after Endovascular Therapy for Aortoiliac Occlusive Disease.
Observational study in Journal of atherosclerosis and thrombosis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Five-Year Outcomes of Endovascular Aortoiliac Reconstruction in Complex Lesions: A Retrospective Single-Center Study.Journal of clinical medicine · 2026Article
- The clinical and physiological profiles of kissing stents in endovascular reconstruction of aortoiliac occlusive disease.Experimental physiology · 2026Review
- Aortoiliac fenestrated stent demonstrates superior flow dynamics to kissing iliac stents in a large animal.JVS-vascular science · 2026Article
- Large animal model validation of a fenestrated balloon-expandable stent for treatment of aortoiliac occlusive disease.Journal of vascular surgery cases and innovative techniques · 2025Article
- Long-Term Follow-up of Subjects With Iliac Occlusive Disease Treated With the Viabahn VBX Balloon-Expandable Endoprosthesis.Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists · 2025Article
- Latest Trend of Endovascular Treatment for Lower Extremity Artery Disease and Recommendations from Interventional Radiologist: To Continue Engaging in This Field Moving Forward.Interventional radiology (Higashimatsuyama-shi (Japan) · 2025Review
- A Patient With Foot Pain Found to Have Leriche Syndrome: A Case Report and Brief Review of the Literature.Cureus · 2023Article
- Endovascular treatment of aorto-iliac occlusive disease with TASC II C and D lesions: 10 year's experience of clinical technique.BMC cardiovascular disorders · 2023Article
- Thrombotic Lesions are Associated with Poor Outcomes after Endovascular Treatment in Patients with Non-Acute Aortoiliac Total Occlusions.Journal of atherosclerosis and thrombosis · 2021Observational
- Long-term impact of high-sensitivity C-reactive protein in patients with intermittent claudication due to peripheral artery disease following endovascular treatment.Heart and vessels · 2021Article
- Primary patency and amputation free survival after endovascular management of infrarenal aorta total occlusions.Anatolian journal of cardiology · 2021Article
- Midterm outcomes of endovascular treatment with bare metal stents for Leriche syndrome patients.Interactive cardiovascular and thoracic surgery · 2021Article
- Spontaneous Collapse of Balloon Expandable Stent in Heavily Calcified Aorta.Annals of vascular diseases · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimAlthough current guidelines recommend surgical revascularization as the first-line therapy for chronic total occlusion of the abdominal aorta (Leriche syndrome), endovascular therapy (EVT) has been increasingly utilized because of the development of new technologies and techniques. EVT has demonstrated durable midterm outcomes for aortoiliac occlusive disease (AIOD). Nonetheless, little is known regarding their long-term outcomes and predictors of restenosis.
methodsWe retrospectively analyzed a multicenter database of 64 consecutive patients (age, 73±10 years; 64% male; 22% critical limb ischemia) undergoing EVT for aortoiliac occlusive disease between September 2005 and March 2016. The outcome measures were primary and secondary patency, following EVT, calculated using the Kaplan-Meier method. Independent predictors associated with restenosis were assessed using Cox proportional hazard regression model.
resultsTechnical success was achieved in 61 patients (95%). In total, 214 stents (192 self-expandable stents, 22 balloon-expandable stents) were implanted. During the follow-up of 33±28 months, 11 patients experienced loss of patency. The primary patency rates were 88%, 70%, and 70% at 1, 3, and 5 years, respectively. The secondary patency rates were 98%, 87%, and 77% at 1, 3, and 5 years, respectively. In Cox regression analysis, E-Luminexx stent use (in 29 patients, 48%) was associated with restenosis [hazard ratio, 4.41, P=0.038].
conclusionIn this retrospective study, EVT for AIOD demonstrated favorable 5-year patency. E-Luminexx stent implantation was associated with restenosis in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.